Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
4204.T Stock Summary
Top 10 Correlated ETFs
4204.T
In the News
4204.T Financial details
Company Rating
Neutral
Market Cap
947.91B
Income
74.89B
Revenue
1254.22B
Book val./share
1736.19
Cash/share
219.03
Dividend
63
Dividend %
2.96%
Employees
26.84K
Optionable
No
Shortable
Yes
Earnings
26 Apr 2024
P/E
12.3
Forward P/E
12.25
PEG
1.11
P/S
0.72
P/B
1.23
P/C
10.18
P/FCF
37.49
Quick Ratio
0.98
Current Ratio
1.97
Debt / Equity
0.16
LT Debt / Equity
0.14
-
-
EPS (TTM)
175.44
EPS next Y
181.99
EPS next Q
39.4
EPS this Y
91.4%
EPS next Y
3.73%
EPS next 5Y
47.29%
EPS last 5Y
2.35%
Revenue last 5Y
1.69%
Revenue Q/Q
-4.07%
EPS Q/Q
-31%
-
-
-
-
SMA20
5.56%
SMA50
4.62%
SMA100
10.33%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
10%
ROC
0.1%
Gross Margin
31%
Oper. Margin
7%
Profit Margin
6%
Payout
34%
Shs Outstand
421.39M
Shs Float
337.16M
-
-
-
-
Target Price
-
52W Range
1786.0-2286.5
52W High
-2.45%
52W Low
+24.86%
RSI
59
Rel Volume
0.45
Avg Volume
1.41M
Volume
640.5K
Perf Week
2.84%
Perf Month
8.91%
Perf Quarter
3.58%
Perf Half Y
0.56%
-
-
-
-
Beta
0.58
-
-
Volatility
17.57%, 55.63%
Prev Close
1%
Price
2230
Change
0.45%
4204.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.45K | 2.46K | 2.34K | 2.6K | 2.86K | |
Net income per share | 141.74 | 128.8 | 91.92 | 83.17 | 159.19 | |
Operating cash flow per share | 182.74 | 201.63 | 166.54 | 235.64 | 164.43 | |
Free cash flow per share | 40.79 | 77.08 | 29.21 | 135.54 | 34.79 | |
Cash per share | 117.64 | 138.08 | 162.72 | 246.24 | 164.32 | |
Book value per share | 1.3K | 1.33K | 1.48K | 1.51K | 1.62K | |
Tangible book value per share | 1.25K | 1.16K | 1.32K | 1.47K | 1.57K | |
Share holders equity per share | 1.3K | 1.33K | 1.48K | 1.51K | 1.62K | |
Interest debt per share | 116.5 | 257.59 | 307.61 | 276.71 | 278.85 | |
Market cap | 863.12B | 658.45B | 960.42B | 783.99B | 816.24B | |
Enterprise value | 847.08B | 699.3B | 1011.13B | 762.01B | 835.62B | |
P/E ratio | 13.06 | 11.13 | 23.12 | 21.15 | 11.78 | |
Price to sales ratio | 0.76 | 0.58 | 0.91 | 0.68 | 0.66 | |
POCF ratio | 10.13 | 7.11 | 12.76 | 7.46 | 11.41 | |
PFCF ratio | 45.38 | 18.59 | 72.74 | 12.98 | 53.93 | |
P/B Ratio | 1.42 | 1.08 | 1.44 | 1.16 | 1.16 | |
PTB ratio | 1.42 | 1.08 | 1.44 | 1.16 | 1.16 | |
EV to sales | 0.74 | 0.62 | 0.96 | 0.66 | 0.67 | |
Enterprise value over EBITDA | 6.26 | 5.25 | 8.96 | 5.2 | 5.35 | |
EV to operating cash flow | 9.94 | 7.55 | 13.43 | 7.26 | 11.68 | |
EV to free cash flow | 44.54 | 19.74 | 76.58 | 12.61 | 55.21 | |
Earnings yield | 0.08 | 0.09 | 0.04 | 0.05 | 0.08 | |
Free cash flow yield | 0.02 | 0.05 | 0.01 | 0.08 | 0.02 | |
Debt to equity | 0.09 | 0.19 | 0.21 | 0.18 | 0.17 | |
Debt to assets | 0.05 | 0.11 | 0.12 | 0.1 | 0.1 | |
Net debt to EBITDA | -0.12 | 0.31 | 0.45 | -0.15 | 0.12 | |
Current ratio | 1.51 | 1.47 | 1.79 | 1.85 | 1.9 | |
Interest coverage | 199.35 | 126.28 | 78.16 | 114.83 | 105.24 | |
Income quality | 0.91 | 1.11 | 1.19 | 1.5 | 0.72 | |
Dividend Yield | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 | |
Payout ratio | 0.3 | 0.36 | 0.5 | 0.58 | 0.34 | |
Sales general and administrative to revenue | 0.17 | 0.17 | 0.18 | 0.16 | 0.16 | |
Research and developement to revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Intangibles to total assets | 0.05 | 0.09 | 0.08 | 0.04 | 0.04 | |
Capex to operating cash flow | -0.78 | -0.62 | -0.82 | -0.42 | -0.79 | |
Capex to revenue | -0.06 | -0.05 | -0.06 | -0.04 | -0.05 | |
Capex to depreciation | -1.59 | -1.26 | -1.26 | -0.92 | -1.08 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.04K | 1.96K | 1.75K | 1.68K | 2.41K | |
ROIC | 0.1 | 0.09 | 0.06 | 0.06 | 0.08 | |
Return on tangible assets | 0.07 | 0.06 | 0.04 | 0.03 | 0.06 | |
Graham Net | -200.53 | -344.82 | -298.51 | -258.09 | -291.6 | |
Working capital | 158.86B | 157.67B | 223.29B | 279.7B | 293.67B | |
Tangible asset value | 581.97B | 533.2B | 596.74B | 656.02B | 681.52B | |
Net current asset value | 79.08B | 23.8B | 49.82B | 113.23B | 126.04B | |
Invested capital | 0.09 | 0.19 | 0.21 | 0.18 | 0.17 | |
Average receivables | 202.62B | 189.4B | 182.29B | 190.2B | 202.2B | |
Average payables | 103.5B | 103.87B | 98.73B | 101.19B | 108.84B | |
Average inventory | 181.32B | 204.69B | 220.05B | 233.37B | 265.32B | |
Days sales outstanding | 62.39 | 59.3 | 62.57 | 62.82 | 60.25 | |
Days payables outstanding | 48.44 | 49.96 | 46.51 | 49.99 | 45.48 | |
Days of inventory on hand | 90.56 | 103.42 | 112.04 | 110.97 | 120.98 | |
Receivables turnover | 5.85 | 6.16 | 5.83 | 5.81 | 6.06 | |
Payables turnover | 7.53 | 7.31 | 7.85 | 7.3 | 8.02 | |
Inventory turnover | 4.03 | 3.53 | 3.26 | 3.29 | 3.02 | |
ROE | 0.11 | 0.1 | 0.06 | 0.05 | 0.1 | |
Capex per share | -141.95 | -124.54 | -137.33 | -100.1 | -129.64 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 702.16 | 768.29 | 667.07 | 766.13 | 736.98 | |
Net income per share | 31.6 | 38.29 | 56.4 | 47.77 | 32.96 | |
Operating cash flow per share | -3.13 | 87.15 | 25.91 | 89.91 | 36.35 | |
Free cash flow per share | -42.67 | 52.87 | -4.94 | 51.37 | -0.49 | |
Cash per share | 160.16 | 192.28 | 167.66 | 281.77 | 219.03 | |
Book value per share | 1.58K | 1.64K | 1.69K | 1.76K | 1.74K | |
Tangible book value per share | 1.53K | 1.59K | 1.63K | 1.69K | 1.67K | |
Share holders equity per share | 1.58K | 1.64K | 1.69K | 1.76K | 1.74K | |
Interest debt per share | 305.28 | 280.84 | 283.31 | 286.32 | 285.03 | |
Market cap | 800.02B | 806.5B | 886.47B | 915.86B | 862.21B | |
Enterprise value | 837.5B | 825.88B | 906B | 899.1B | 871.7B | |
P/E ratio | 14.6 | 12.25 | 9.18 | 11.27 | 15.42 | |
Price to sales ratio | 2.63 | 2.44 | 3.11 | 2.81 | 2.76 | |
POCF ratio | -589.11 | 21.53 | 79.96 | 23.95 | 55.92 | |
PFCF ratio | -43.24 | 35.49 | -419.13 | 41.92 | -4.19K | |
P/B Ratio | 1.17 | 1.14 | 1.23 | 1.23 | 1.17 | |
PTB ratio | 1.17 | 1.14 | 1.23 | 1.23 | 1.17 | |
EV to sales | 2.75 | 2.5 | 3.17 | 2.76 | 2.79 | |
Enterprise value over EBITDA | 25.86 | 18.45 | 25.92 | 21.06 | 24.96 | |
EV to operating cash flow | -616.72 | 22.04 | 81.72 | 23.51 | 56.53 | |
EV to free cash flow | -45.27 | 36.34 | -428.37 | 41.15 | -4.23K | |
Earnings yield | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | |
Free cash flow yield | -0.02 | 0.03 | 0 | 0.02 | 0 | |
Debt to equity | 0.19 | 0.17 | 0.17 | 0.16 | 0.16 | |
Debt to assets | 0.11 | 0.1 | 0.1 | 0.1 | 0.1 | |
Net debt to EBITDA | 1.16 | 0.43 | 0.56 | -0.39 | 0.27 | |
Current ratio | 1.8 | 1.9 | 1.91 | 1.97 | 1.95 | |
Interest coverage | 98.76 | 105.8 | 55.18 | 76.31 | 101.14 | |
Income quality | -0.07 | 1.42 | 0.31 | 1.3 | 0.74 | |
Dividend Yield | 0.02 | 0 | 0.01 | 0 | 0.02 | |
Payout ratio | 0.93 | 0 | 0.54 | 0 | 1.07 | |
Sales general and administrative to revenue | 0 | 0.09 | 0 | 0 | 0 | |
Research and developement to revenue | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | |
Intangibles to total assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | |
Capex to operating cash flow | 12.62 | -0.39 | -1.19 | -0.43 | -1.01 | |
Capex to revenue | -0.06 | -0.04 | -0.05 | -0.05 | -0.05 | |
Capex to depreciation | -1.36 | -0.99 | -1.06 | -1.26 | -1.17 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.06K | 1.19K | 1.46K | 1.37K | 1.13K | |
ROIC | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | |
Return on tangible assets | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | |
Graham Net | -331.35 | -269.15 | -271.27 | -158.31 | -204.39 | |
Working capital | 273.54B | 293.67B | 299.73B | 327.05B | 315.03B | |
Tangible asset value | 661.67B | 681.52B | 696.36B | 718.1B | 707.58B | |
Net current asset value | 106.38B | 126.04B | 143.23B | 171.2B | 159.37B | |
Invested capital | 0.19 | 0.17 | 0.17 | 0.16 | 0.16 | |
Average receivables | 200.83B | 202.68B | 200.33B | 203.58B | 210.45B | |
Average payables | 107.65B | 107.7B | 104.65B | 103.13B | 105.42B | |
Average inventory | 280.45B | 287.81B | 295.63B | 300.31B | 299.25B | |
Days sales outstanding | 59.19 | 55.89 | 61.66 | 58.44 | 60.25 | |
Days payables outstanding | 46.01 | 42.21 | 46.18 | 41.85 | 44.86 | |
Days of inventory on hand | 123.52 | 112.28 | 138.54 | 118.27 | 127.88 | |
Receivables turnover | 1.52 | 1.61 | 1.46 | 1.54 | 1.49 | |
Payables turnover | 1.96 | 2.13 | 1.95 | 2.15 | 2.01 | |
Inventory turnover | 0.73 | 0.8 | 0.65 | 0.76 | 0.7 | |
ROE | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | |
Capex per share | -39.54 | -34.29 | -30.86 | -38.55 | -36.83 |
4204.T Frequently Asked Questions
What is Sekisui Chemical Co., Ltd. stock symbol ?
Sekisui Chemical Co., Ltd. is a JP stock and trading under the symbol 4204.T
What is Sekisui Chemical Co., Ltd. stock quote today ?
Sekisui Chemical Co., Ltd. stock price is $2230 today.
Is Sekisui Chemical Co., Ltd. stock public?
Yes, Sekisui Chemical Co., Ltd. is a publicly traded company.